scispace - formally typeset
Open AccessJournal ArticleDOI

Nanoparticle-detained toxins for safe and effective vaccination

TLDR
It is found that the non-disruptive detoxification approach benefited the immunogenicity and efficacy of toxoid vaccines, and mice vaccinated with the nanoparticle-detained toxin showed superior protective immunity against toxin adverse effects.
Abstract
Toxoid vaccines--vaccines based on inactivated bacterial toxins--are routinely used to promote antitoxin immunity for the treatment and prevention of bacterial infections. Following chemical or heat denaturation, inactivated toxins can be administered to mount toxin-specific immune responses. However, retaining faithful antigenic presentation while removing toxin virulence remains a major challenge and presents a trade-off between efficacy and safety in toxoid development. Here, we show a nanoparticle-based toxin-detainment strategy that safely delivers non-disrupted pore-forming toxins for immune processing. Using erythrocyte membrane-coated nanoparticles and staphylococcal α-haemolysin, we demonstrate effective virulence neutralization via spontaneous particle entrapment. Compared with vaccination with heat-denatured toxin, mice vaccinated with the nanoparticle-detained toxin showed superior protective immunity against toxin-mediated adverse effects. We find that the non-disruptive detoxification approach benefited the immunogenicity and efficacy of toxoid vaccines. We anticipate that this study will open new possibilities in the preparation of antitoxin vaccines against the many virulence factors that threaten public health.

read more

Citations
More filters
Journal ArticleDOI

Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery

TL;DR: The biological functionalization of polymeric nanoparticles with a layer of membrane coating derived from cancer cells is reported on, showing that by coupling the particles with an immunological adjuvant, the resulting formulation can be used to promote a tumor-specific immune response for use in vaccine applications.
Journal ArticleDOI

Cell Membrane Coating Nanotechnology

TL;DR: There is still significant room for development, as researchers continue to refine existing workflows while finding new and exciting applications that can take advantage of this developing technology, cell‐membrane‐coating nanotechnology.
Journal ArticleDOI

Cancer Cell Membrane Camouflaged Cascade Bioreactor for Cancer Targeted Starvation and Photodynamic Therapy.

TL;DR: A cancer targeted cascade bioreactor was constructed by embedding glucose oxidase and catalase in the cancer cell membrane-camouflaged porphyrin metal-organic framework of PCN-224 to enhance its cancer targeting and retention abilities and displayed amplified synergistic therapeutic effects of long-term cancer starvation therapy and robust PDT.
Journal ArticleDOI

Cancer Cell Membrane–Biomimetic Nanoparticles for Homologous-Targeting Dual-Modal Imaging and Photothermal Therapy

TL;DR: A cancer cell membrane-cloaked nanoparticle system as a theranostic nanoplatform with homologous properties of cancer cell membranes can serve as a bionic nanoplplatform for cancer-targeted imaging and phototherapy.
References
More filters
Journal ArticleDOI

Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform

TL;DR: A top-down biomimetic approach in particle functionalization is reported by coating biodegradable polymeric nanoparticles with natural erythrocyte membranes, including both membrane lipids and associated membrane proteins for long-circulating cargo delivery.
Journal ArticleDOI

Immunological properties of engineered nanomaterials.

TL;DR: Research shows that nanoparticles can stimulate and/or suppress the immune responses, and that their compatibility with the immune system is largely determined by their surface chemistry, and modifying these factors can significantly reduce the immunotoxicity of nanoparticles and make them useful platforms for drug delivery.
Journal ArticleDOI

Exploiting lymphatic transport and complement activation in nanoparticle vaccines.

TL;DR: In this article, the authors investigate whether nanoparticles can be used as a vaccine platform by targeting lymph node-residing dendritic cells via interstitial flow and activating these cells by in situ complement activation.
Journal Article

Exploiting lymphatic transport and complement activation in nanoparticle vaccines

TL;DR: This work investigates whether nanoparticles can be used as a vaccine platform by targeting lymph node–residing dendritic cells via interstitial flow and activating these cells by in situ complement activation, and demonstrates generation of humoral and cellular immunity in mice in a size- and complement-dependent manner.
Related Papers (5)